Vasey, C.E.; Cavanagh, R.J.; Taresco, V.; Moloney, C.; Smith, S.; Rahman, R.; Alexander, C.
Polymer Pro-Drug Nanoparticles for Sustained Release of Cytotoxic Drugs Evaluated in Patient-Derived Glioblastoma Cell Lines and In Situ Gelling Formulations. Pharmaceutics 2021, 13, 208.
https://doi.org/10.3390/pharmaceutics13020208
AMA Style
Vasey CE, Cavanagh RJ, Taresco V, Moloney C, Smith S, Rahman R, Alexander C.
Polymer Pro-Drug Nanoparticles for Sustained Release of Cytotoxic Drugs Evaluated in Patient-Derived Glioblastoma Cell Lines and In Situ Gelling Formulations. Pharmaceutics. 2021; 13(2):208.
https://doi.org/10.3390/pharmaceutics13020208
Chicago/Turabian Style
Vasey, Catherine E., Robert J. Cavanagh, Vincenzo Taresco, Cara Moloney, Stuart Smith, Ruman Rahman, and Cameron Alexander.
2021. "Polymer Pro-Drug Nanoparticles for Sustained Release of Cytotoxic Drugs Evaluated in Patient-Derived Glioblastoma Cell Lines and In Situ Gelling Formulations" Pharmaceutics 13, no. 2: 208.
https://doi.org/10.3390/pharmaceutics13020208
APA Style
Vasey, C. E., Cavanagh, R. J., Taresco, V., Moloney, C., Smith, S., Rahman, R., & Alexander, C.
(2021). Polymer Pro-Drug Nanoparticles for Sustained Release of Cytotoxic Drugs Evaluated in Patient-Derived Glioblastoma Cell Lines and In Situ Gelling Formulations. Pharmaceutics, 13(2), 208.
https://doi.org/10.3390/pharmaceutics13020208